$WAT

Waters earnings beat by $0.10, revenue topped estimates

Waters (WAT) reported Q3 EPS of $4.10, beating estimates by $0.10, with revenue at $1.77B, exceeding expectations. The company provided Q4 and FY 2026 guidance, with EPS and revenue estimates generally in line with or slightly above consensus. WAT's stock is up 12.47% over the last 3 months and 22.37% over the last 12 months.

Original reporting
Published Nov 3, 2026, 11:12 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 11:24 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$WAT
Bullish
high confidence
Mentioned
$WAT
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$WATBullishHigh
01

Why it matters

The earnings beat and raised guidance are fresh disclosures that can influence trading decisions today.

02

Market read

Fresh earnings data and guidance lift the stock, making it a near‑term trading opportunity.

03

What to watch

Potential supply‑chain constraints or macro‑economic headwinds could temper upside.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Waters (NYSE:WAT) is a specialty chemicals maker. The article provides its Q3 results and FY guidance.

Company-level read

Ticker impact

$WATBullishHigh confidence
Context

Waters reported Q3 earnings beat and raised FY guidance, providing fresh material for traders.

Expected impact

likely upward pressure as market prices in the beat and higher guidance

Evidence & confidence

The company posted EPS $0.10 above estimates and lifted FY revenue and EPS forecasts, which typically drives buying interest.

Market effects

Positive earnings may lift the specialty chemicals sector and peers.

U.S. market sentiment could improve for industrial stocks.

Limited to investors tracking U.S. listed specialty chemicals.

Counterpoint

If the beat is already priced in, the stock could face short‑term profit taking.

Key entities

  • Waters

    U.S. listed specialty chemicals manufacturer.

Related articles

$WATHighAI 8/10

Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results

WATERS CORP /DE/ (WAT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 For Immediate Release Contact: Caspar Tudor, Head of Investor Relations – (508) 482-3448 Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results Company to Provide Starting 2027 Growth Framework on Earnings Conference Call Third Quarter 2026 Highl

$WATHighAI 8/10

Waters Corp. Q3 Adjusted EPS Rises 21%; Raises Annual Outlook; Stock Up

Waters Corp. (WAT) reported Q3 net income fell to $81M ($0.82 EPS) due to costs, but adjusted EPS rose 21% to $4.10. Revenue hit $1.767B, with organic growth of 9%. The company raised its 2026 outlook, expecting organic revenue growth of 9.1% to 9.7% and adjusted EPS of $14.60 to $14.70. Shares rose 6% in pre-market trading.

$WATMed

Waters Acquires MOBILion Systems To Expand Proteomics Business

Waters Corp. (WAT) acquired MOBILion Systems to expand its proteomics business. The deal combines MOBILion's SLIM tech with Waters' Xevo MRT platform, aiming to enhance protein research. The LC-MS proteomics market is valued at $2B with high single-digit annual growth. Financial terms were not disclosed.

$WATHighAI 8/10

Waters beats Q3 estimates, raises full-year guidance

Waters Corporation (NYSE:WAT) reported Q3 adjusted EPS of $4.10, beating estimates by $0.10, with revenue of $1.77B, up 121% YoY. The company raised full-year 2026 guidance, expecting adjusted EPS of $14.60-$14.70 and revenue of $6.48B-$6.50B. Q4 guidance was mixed. Organic revenue grew 9%, driven by strong divisional performance. The company also acquired MOBILion Systems, Inc.